Ipswich Town transfer rumour: Blues ‘make initial enquiry’ for Boro striker Gestede
- Credit: PA Archive/PA Images
Ipswich Town are said to have made an enquiry regarding Middlesbrough striker Rudy Gestede.
The French-born Benin international forward is a target for Town boss Paul Lambert, according to the Telegraph, with the Scot said to have made contact with Middlesbrough ahead of the opening of the January transfer window.
Gestede is set to be made available by Tony Pulis, according to the report.
The 30-year-old was a £6 million signing for Middlesbrough from Aston Villa in January 2017 but has only managed four goals in 39 league appearances at the Riverside.
Gestede’s most prolific spell came at Blackburn, with the 6ft 4inch striker netting 32 times in 60 games during a profitable partnership with former Blue Jordan Rhodes between 2014 and 2015.
Former Ipswich striker Daryl Murphy was linked with a potential return to the Blues earlier today but, while the Irish striker is admired by those within the club, no contact with Forest has been made at this stage.
It’s understood Murphy is happy at the City Ground despite only making nine appearances this season, and is not looking for a move away.
You may also want to watch:
A striker with Championship experience is top of Lambert’s January shopping list, with the Scot using converted winger Jordan Roberts as his centre forward for the majority of his tenure to date.
- 1 Covid vaccines cancelled at four Suffolk centres today – this is why
- 2 'Dedicated' volunteer police officer dies after having Covid-19
- 3 New cheese afternoon tea launched in Suffolk
- 4 Huge numbers of Covid vaccine bookings in Suffolk
- 5 Floods as river bursts its banks at beauty spot
- 6 Ipswich closing in on Thomas signing, as club await Harrop medical results
- 7 Three fined for breaching Covid rules after reports of 'gathering'
- 8 Where Ipswich Town are at with ins and outs during the January transfer window
- 9 Latest 'R rate' shows coronavirus still spreading in region
- 10 Suffolk coronavirus vaccine concerns – your questions answered